American Journal of Epidemiology Vol. 150, No. 9: 963-968
Copyright © 1999 by The Johns Hopkins University School of Hygiene and Public Health
other |
Is Age-related Maculopathy Associated with Alzheimer's Disease?: The Rotterdam Study
1Department of Epidemiology and Biostatistics, Erasmus University Medical School Rotterdam, the Netherlands
2Department of Ophthalmology, Erasmus University Medical School Rotterdam, the Netherlands
3The Netherlands Ophthalmic Research Institute Amsterdam, the Netherlands
4Department of Ophthalmology, Academic Medical Center Amsterdam, the Netherlands
The authors examined the relation between age-related maculopathy and Alzheimer's disease in the Rotterdam Study, a prospective population-based study in the Netherlands. From 1990 to mid-1993, subjects aged 75 years or older (n = 1,438) were screened for the presence of age-related maculopathy and Alzheimer's disease, and follow-up examinations were conducted from mid-1993 to the end of 1994. Subjects with advanced age-related maculopathy at baseline showed an increased risk of incident Alzheimer's disease (relative risk = 2.1, 95% confidence interval: 1.1, 4.3; adjusted for age and gender), but this risk decreased after additional adjustment for smoking and atherosclerosis (relative risk = 1.5, 95% confidence interval: 0.6, 3.5). These findings suggest that the neuronal degeneration occurring in age-related maculopathy and Alzheimer's disease may, to some extent, have a common pathogenesis. Am J Epidemiol 1999;150:963-8.
aging; Alzheimer disease; atherosclerosis; comorbidity; incidence; macular degeneration; neurodegenerative diseases; smoking
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. L. Baker, J. J. Wang, S. Rogers, R. Klein, L. H. Kuller, E. K. Larsen, and T. Y. Wong Early Age-Related Macular Degeneration, Cognitive Function, and Dementia: The Cardiovascular Health Study Arch Ophthalmol, May 1, 2009; 127(5): 667 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Perez, S. Lumayag, B. Kovacs, E. J. Mufson, and S. Xu {beta}-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1{Delta}E9 Transgenic Mouse Model of Alzheimer's Disease Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hye, S. Lynham, M. Thambisetty, M. Causevic, J. Campbell, H. L. Byers, C. Hooper, F. Rijsdijk, S. J. Tabrizi, S. Banner, et al. Proteome-based plasma biomarkers for Alzheimer's disease. Brain, November 1, 2006; 129(Pt 11): 3042 - 3050. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Wong, R. Klein, C. Sun, P. Mitchell, D. J. Couper, H. Lai, L. D. Hubbard, A. R. Sharrett, and for the Atherosclerosis Risk in Communities Study Age-Related Macular Degeneration and Risk for Stroke Ann Intern Med, July 18, 2006; 145(2): 98 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
Age-Related Eye Disease Study Research Group Cognitive Impairment in the Age-Related Eye Disease Study: AREDS Report No. 16. Arch Ophthalmol, April 1, 2006; 124(4): 537 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Johnson, W. P. Leitner, A. J. Rivest, M. K. Staples, M. J. Radeke, and D. H. Anderson The Alzheimer's Abeta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration PNAS, September 3, 2002; 99(18): 11830 - 11835. [Abstract] [Full Text] [PDF] |
||||




